Clinical Trial Update: 18F-mFBG Imaging for Myocardial Sympathetic Innervation [Phase 2]

View source ↗

Summary

Phase 2 trial update for the 18F-mFBG imaging agent to assess myocardial sympathetic innervation in heart failure and ischemic cardiomyopathy, with the study cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ischemic Cardiomyopathy

Drugs mentioned

• [18F]-MFBG (18F-MFBG)

Snippet

Sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | Conditions: Heart Failure, Ischemic Cardiomyopathy | Phase 2 | Status: NOT_YET_RECRUITING